Welcome to LookChem.com Sign In|Join Free

CAS

  • or
hemibrevetoxin B is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

122271-91-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 122271-91-4 Structure
  • Basic information

    1. Product Name: hemibrevetoxin B
    2. Synonyms: hemibrevetoxin B
    3. CAS NO:122271-91-4
    4. Molecular Formula: C28H42O7
    5. Molecular Weight: 490.62888
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 122271-91-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 655.5°Cat760mmHg
    3. Flash Point: 211.9°C
    4. Appearance: /
    5. Density: 1.104g/cm3
    6. Vapor Pressure: 5.78E-20mmHg at 25°C
    7. Refractive Index: 1.509
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: hemibrevetoxin B(CAS DataBase Reference)
    11. NIST Chemistry Reference: hemibrevetoxin B(122271-91-4)
    12. EPA Substance Registry System: hemibrevetoxin B(122271-91-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 122271-91-4(Hazardous Substances Data)

122271-91-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 122271-91-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,2,7 and 1 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 122271-91:
(8*1)+(7*2)+(6*2)+(5*2)+(4*7)+(3*1)+(2*9)+(1*1)=94
94 % 10 = 4
So 122271-91-4 is a valid CAS Registry Number.
InChI:InChI=1/C28H42O7/c1-5-6-7-8-9-24-27(3,31)12-10-21-22(33-24)11-13-28(4)25(34-21)16-23-26(35-28)20(30)15-19(32-23)14-18(2)17-29/h5-7,17,19-26,30-31H,1-2,8-16H2,3-4H3/b7-6-/t19-,20+,21-,22+,23-,24-,25+,26+,27+,28-/m1/s1

122271-91-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name Hemibrevetoxin B

1.2 Other means of identification

Product number -
Other names Hemibrevetoxin-B

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:122271-91-4 SDS

122271-91-4Downstream Products

122271-91-4Relevant articles and documents

Total synthesis of hemibrevetoxin B

Morimoto, Masamichi,Matsukura, Hiroko,Nakata, Tadashi

, p. 6365 - 6368 (1996)

Total synthesis of hemibrevetoxin B was stereoselectively accomplished based on a novel double rearrangement-ring expansion of a 6,6-membered ether to a 7,7-membered ether, an exclusive 6-endo-cyclization of hydoxy styrylepoxide, and a direct introduction of a C-4 unit as the side chain on the A-ring.

Stereocontrolled Total Synthesis of Hemibrevetoxin B

Kadota, Isao,Yamamoto, Yoshinori

, p. 6597 - 6606 (2007/10/03)

The stereocontrolled total synthesis of hemibrevetoxin B (1) has been achieved in 56 steps and 0.75% overall yield from D-mannose. The intramolecular reaction of γ-alkoxyallylstannane with aldehyde is a key step for the present total synthesis. Thus, the BF3·OEt2-mediated reaction of 24 gave 6 as a sole product. We encountered difficulty in the synthesis of γ-alkoxyallylstannane 30 from the corresponding allyl ether 29 in which the γ-alkoxy substituent became sterically quite bulky. This problem was solved by developing the acetal cleavage method for the synthesis of γ-alkoxyallylstannanes. The cyclization of 38 proceeded smoothly to give the key intermediate 5 in a highly stereoselective manner. Construction of the α-vinyl aldehyde and (Z)-diene moieties were performed using Nicolaou's protocol.

Total synthesis of hemibrevetoxin B

Kadota, Isao,Jung-Youl, Park,Koumura, Nagatoshi,Pollaud, Guy,Matsukawa, Yasuhisa,Yamamoto, Yoshinori

, p. 5777 - 5780 (2007/10/02)

The total synthesis of Hemibrevetoxin B is described. A new cyclization approach, based on the Lewis acid mediated intramolecular cyclization of the γ-oxo-substituted allylic tin having an aldehyde group, produced the 6-6-7-7 polycyclic ether skeleton of

Total synthesis of hemibrevetoxin B and (7aα)-epi-hemibrevetoxin B

Nicolaou,Reddy, K. Raja,Skokotas, Golfo,Sato, Fuminori,Xiao, Xiao-Yi,Hwang

, p. 3558 - 3575 (2007/10/02)

The total synthesis of hemibrevetoxin B(1) and (7aα)-epi-hemibrevetoxin B (2) is described. The synthesis of the epimer (2) was achieved through a convergent approach involving coupling of the carboxylic acid 17 carrying the bicyclic pyran system with the hydroxy compound 31 containing the monocyclic pyran system, thionation of the resulting diester 32 to the dithionoester 33, photolytic closure to the oxepane enol ether 34, and hydroxy ketone cyclization to the dioxepane system 40. The Z-diene system was established using a selenyl-Wittig reaction followed by syn elimination of the selenoxide to the diene. The α-vinyl functionality was installed using the Eschenmoser's salt methodology. The synthesis of hemibrevetoxin B(1) was achieved through a linear approach involving sequential formation of the oxepane rings (65 → 67 → 73) using the method of thionolactone formation followed by nucleophilic addition and regio/stereoselective hydroboration (67 → 68, 75 → 76). Elaboration of the side chains was carried out in a similar fashion as described for the epimer. The stereochemistry of the ring junctures in 1 and 2 and intermediates leading to them was established by X-ray crystallographic analysis carried out on compounds 45 and 54. Biological studies with (7aα)-epi-hemibrevetoxin B (2) revealed no binding for this molecule to the brevetoxin receptors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 122271-91-4